Day: May 3, 2021

Tattooed Chef Enters into Agreements to Acquire New Mexico Food Distributors, Inc. and Karsten Tortilla Factory, LLC

Written by Customer Service on May 3, 2021. Posted in Mergers And Acquisitions.

Will Expand Manufacturing Capacity and Product Portfolio with Full Array of Mexican Plant-Based Foods Transactions Expected to Close in Early May Company Updates 2021 Outlook PARAMOUNT, Calif., May 03, 2021 (GLOBE NEWSWIRE) — Tattooed Chef, Inc. (Nasdaq: TTCF) (“Tattooed Chef” or the “Company”), a leader in plant-based foods, today announced it has entered into agreements to acquire New Mexico Food Distributors, Inc. and Karsten Tortilla Factory, LLC (collectively referred to as “Foods of New Mexico”) for approximately $35 million in cash. The transactions have been unanimously approved by Tattooed Chef’s Board of Directors. Tattooed Chef expects to close the transactions in early May, subject to customary closing conditions. Founded in 1987 and headquartered in Albuquerque, New Mexico, Foods of New Mexico is a prepared food company...

Verizon Media to be Acquired by Apollo Funds

Written by Customer Service on May 3, 2021. Posted in Mergers And Acquisitions.

Transaction Expected to Accelerate Growth of the Internet and Digital Media Leader Verizon to Maintain Minority Stake in the New Company to be Known as Yahoo NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) — Verizon (NYSE: VZ) and Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo”) today announced that funds managed by affiliates of Apollo (the “Apollo Funds”) entered into an agreement to acquire Verizon Media for $5 billion. Verizon will retain a 10% stake in the company, which will be known as Yahoo at close of the transaction and continue to be led by CEO Guru Gowrappan. One of the world’s premier global technology and media companies, Verizon Media is comprised of iconic brands such as Yahoo and AOL, as well as leading ad tech and media platform businesses. The corporate carveout will...

Altisource Portfolio Solutions S.A. Schedules First Quarter 2021 Conference Call

Written by Customer Service on May 3, 2021. Posted in Public Companies.

LUXEMBOURG, May 03, 2021 (GLOBE NEWSWIRE) — On Monday, May 10, 2021, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the first quarter 2021. A press release and presentation will be available on Altisource’s website in the Investor Relations section. Altisource will also host a conference call at 8:30 a.m. EST on the same day to discuss its first quarter 2021 results. A link to the live audio webcast will be available on Altisource’s website in the Investor Relations section. Those who want to listen to the call should go to the website at least fifteen minutes prior to the call to register, download and install any necessary audio software. A replay of the conference call will be available via the website approximately two hours after the conclusion of the call and will remain available...

Guardion Health Sciences Initiates Placebo-Controlled Clinical Trial Involving Proprietary GlaucoCetin® Product

Written by Customer Service on May 3, 2021. Posted in Public Companies.

Clinical Trial Intended to Demonstrate Improved Visual Function in Glaucoma Patients Taking GlaucoCetin® SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements and medical devices, announced the initiation of a placebo-controlled clinical trial to study the impact on visual function, as measured by visual field sensitivity, in patients with glaucoma after a 12-week regimen of GlaucoCetin®. GlaucoCetin is the Company’s proprietary medical food designed to provide support for mitochondrial activity in optic nerve cells. Mitochondrial dysfunction and loss of activity is now thought to be a key factor for vision loss from glaucoma, as well as other common...

TRACON Pharmaceuticals Announces Appointment of Dongliang Zhuang, Ph.D. as Vice President of Statistics and Biometrics

Written by Customer Service on May 3, 2021. Posted in Public Companies.

SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., announced today the appointment of Dongliang Zhuang, Ph.D. as Vice President of Statistics and Biometrics. “We are very pleased to welcome Dongliang to the TRACON senior management team,” said Charles Theuer, M.D., Ph.D., President and CEO of TRACON. “His strong experience at the U.S. FDA and on BLA submissions at biopharmaceutical companies will be invaluable to TRACON as we execute on our plan to complete the ENVASARC trial and begin activities expected...

Aeterna Zentaris Appoints Michael Teifel, Ph.D. as Senior Vice President, Non-Clinical Development and Chief Scientific Officer

Written by Customer Service on May 3, 2021. Posted in Public Companies.

– Over 20 years of industry experience in translating research into clinical development in a wide range of therapeutic areas of endocrinology and oncology CHARLESTON, S.C., May 03, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced the appointment of Michael Teifel, Ph.D. as Senior Vice President, Non-Clinical Development and Chief Scientific Officer. Dr. Teifel is a leading industry executive with a career spanning over 20 years in various therapeutic areas, including endocrinology and oncology. He has deep experience in translating research into clinical development. Over the course of his career, he has gained particular expertise in the...

Catalyst Pharmaceuticals to Hold First Quarter 2021 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, May 11th, 2021

Written by Customer Service on May 3, 2021. Posted in Public Companies.

CORAL GABLES, Fla., May 03, 2021 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, today announced that it will release first quarter 2021 financial results after market close on Monday, May 10, 2021. Further, Catalyst management will host an investment-community conference call at 8:30 a.m. ET on Tuesday, May 11, 2021 to discuss the financial results and to provide a corporate update. Investors who wish to participate in the conference call may do so by dialing (877) 407-8912 for domestic and Canadian callers or (201) 689-8059 for international callers. Those interested in listening to the conference call live via the...

TanGold Introduces New Discovery – Buckreef West Gold Zone Near Surface – Open at Depth & to the South

Written by Customer Service on May 3, 2021. Posted in Public Companies.

Figure 1: Map with Recent Results from the Buckreef West Drilling CampaignFigure 1: Map with Recent Results from the Buckreef West Drilling CampaignTable 1: Summary Table of Buckreef West Assay ResultsTable 1: Summary Table of Buckreef West Assay ResultsFigure 2: Aerial Composite with Select Intercepts – Highlighting the Position of Buckreef West vs. the Buckreef Main ZoneFigure 2: Aerial Composite with Select Intercepts – Highlighting the Position of Buckreef West vs. the Buckreef Main ZoneTORONTO, May 03, 2021 (GLOBE NEWSWIRE) — Tanzanian Gold Corporation (TSX:TNX) (NYSE American:TRX) (TanGold or the Company) operating through its wholly owned subsidiary in Tanzania (Tanzam2000), and its joint venture partner, The State Mining Company (STAMICO), is pleased to expand...

MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for Shareholders

Written by Customer Service on May 3, 2021. Posted in Public Companies.

Urges Shareholders to Vote the WHITE Proxy Card “FOR ALL” Four of MIMEDX’s Director Nominees – Dr. Kathleen Behrens, Mr. Todd Newton, Mr. Timothy Wright, and Dr. Phyllis Gardner Entirely Reconstituted Board and New Management Team Positioned Company for Long-Term Sustainable Growth; Stock Price Appreciation of 237% Since Timothy Wright Selected as CEO Virtual Annual Meeting to Be Held on May 27, 2021 MARIETTA, Ga., May 03, 2021 (GLOBE NEWSWIRE) — MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that it has filed definitive proxy materials with the U.S. Securities and Exchange Commission in connection with its 2021 Annual Meeting of Shareholders (“Annual Meeting”), to be held virtually on May 27, 2021 at 10:00 a.m....

Pretium Resources Inc.: Underground Exploration Drilling at Brucejack Extends Mineralization Below the Current Mining Levels and Intercepts High-Grade Gold to the East

Written by Customer Service on May 3, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, May 03, 2021 (GLOBE NEWSWIRE) — Pretium Resources Inc. (TSX/NYSE: PVG) (“Pretivm” or the “Company”) today announces that underground exploration drilling conducted in 2020 from the 1080 Level, one of the lowest mining levels at the Brucejack Mine, intercepted high-grade gold mineralization at depth and to the east of the Valley of the Kings deposit. “These results continue to highlight the potential to extend beyond the defined resource and confirm that the Valley of the Kings deposit remains open at depth,” said Jacques Perron, President and Chief Executive Officer of Pretivm. “A new extension of gold mineralization was also intercepted immediately to the east of the existing underground infrastructure that could provide easy access for future development. Our follow-up underground resource expansion...

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

Day: May 3, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals